Skip to main content

Daily Toothbrushing Cuts Hospital-Acquired Pneumonia

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 22, 2023.

By Lori Solomon HealthDay Reporter

FRIDAY, Dec. 22, 2023 -- Daily toothbrushing among hospitalized patients is associated with lower rates of hospital-acquired pneumonia (HAP) and improved outcomes, according to a review published online Dec. 18 in JAMA Internal Medicine.

Selina Ehrenzeller, M.D., and Michael Klompas, M.D., M.P.H., from Harvard University in Boston, conducted a systematic literature review and meta-analysis to assess whether daily toothbrushing may be an effective strategy to prevent HAP.

Based on 15 included trials (10,742 patients), the researchers found that toothbrushing was associated with a significantly lower risk for HAP (risk ratio [RR], 0.67) and intensive care unit (ICU) mortality (RR, 0.81). This reduction in pneumonia incidence was significant for patients receiving invasive mechanical ventilation (RR, 0.68) but not for patients who were not receiving invasive mechanical ventilation. Furthermore, toothbrushing for patients in the ICU was associated with fewer days of mechanical ventilation (mean difference, −1.24 days) and a shorter ICU length of stay (mean difference, −1.78 days). Similar effect estimates were seen for brushing twice a day or at more frequent intervals. When restricting the analysis to seven studies at low risk for bias (1,367 patients), results were similar. No association was seen for toothbrushing on non-ICU hospital length of stay and use of antibiotics.

"Programs and policies to encourage daily toothbrushing are warranted," the authors write.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

FDA Approves Capvaxive Pneumococcal 21-Valent Conjugate Vaccine

FRIDAY, June 21, 2024 -- The U.S. Food and Drug Administration has approved the Capvaxive pneumococcal 21-valent conjugate vaccine for the prevention of invasive pneumococcal...

Chronic Kidney Disease Tied to Tooth Loss After Menopause

MONDAY, June 17, 2024 -- In postmenopausal women, chronic kidney disease (CKD) may be associated with tooth loss, according to a study published online June 11...

Periodontitis May Modify Risk for Atrial Fibrillation

THURSDAY, April 11, 2024 -- Periodontitis is a risk factor for atrial fibrillation (AF), according to a study published online April 10 in the Journal of the American Heart...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.